Our data show that IL-1β has a similar effect in GG and TSC and this effect was blocked by the specific receptor antagonist IL-1Ra confirming that it was mediated by the activation of the IL-1β receptor and associated molecular cascade as previously reported23. This evidence concerns the gene IL1B and tuberous sclerosis.